MicroRNA‑497‑5p downregulation inhibits cell viability, reduces extracellular matrix deposition and induces apoptosis in human hyperplastic scar fibroblasts by regulating Smad7

Li,Zhiqiang; Wang,Pengtao; Zhang,Jie; Zhao,Dongkui

doi:10.3892/etm.2021.9815

MicroRNA‑497‑5p downregulation inhibits cell viability, reduces extracellular matrix deposition and induces apoptosis in human hyperplastic scar fibroblasts by regulating Smad7

Authors:
- Zhiqiang Li
- Pengtao Wang
- Jie Zhang
- Dongkui Zhao
View Affiliations

Affiliations: Shanghai Meizhizhen Medical Cosmetology Clinic, Shanghai 200122, P.R. China
Published online on: February 23, 2021 https://doi.org/10.3892/etm.2021.9815
Article Number: 384
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypertrophic scars (HSs) are characterized by excessive extracellular matrix deposition and excessive growth of dense fibrous tissues. MicroRNAs (miRNAs/miRs) serve key roles in HS formation. The present study investigated the expression, role and mechanism underlying the effects of miR‑497‑5p in HS formation. miR‑497‑5p expression was detected via reverse transcription‑quantitative PCR. The association between miR‑497‑5p and Smad7 was analyzed using TargetScan and luciferase reporter assays. Protein expression levels of extracellular matrix markers were measured via western blotting. Cell viability and apoptosis were determined using the Cell Counting Kit‑8 assay and flow cytometry, respectively. The results suggested that miR‑497‑5p expression was upregulated in HS tissues and human HS fibroblasts (hHSFs) compared with healthy control skin tissues and CCC‑ESF‑1 cells, respectively. Smad7 was directly targeted by miR‑497‑5p, and was downregulated in HS tissues and hHSFs compared with healthy control skin tissues and CCC‑ESF‑1 cells, respectively. Moreover, Smad7 upregulation significantly inhibited cell viability, decreased extracellular matrix deposition and induced apoptosis in hHSFs compared with the control‑plasmid group. Moreover, the results indicated that, compared with the inhibitor control group, miR‑497‑5p inhibitor inhibited cell viability, decreased extracellular matrix deposition and induced apoptosis in hHSFs, which were significantly reversed by Smad7 knockdown. In conclusion, the results indicated that miR‑497‑5p downregulation repressed HS formation by inhibiting extracellular matrix deposition and hHSF proliferation at least partly by targeting Smad7.

View Figures

View References

1	Gabriel V: Hypertrophic scar. Phys Med Rehabil Clin N Am. 22:301–310. 2011.PubMed/NCBI View Article : Google Scholar
2	Fan SQ, Cai JL, Qin LY, Wang ZH, Liu ZZ and Sun ML: Effect of heparin on production of transforming growth factor (TGF)-betal and TGF-betal mRNA expression by human normal skin and hyperplastic scar fibroblasts. Ann Plast Surg. 60:299–305. 2008.PubMed/NCBI View Article : Google Scholar
3	Gauglitz GG, Korting HC, Pavicic T, Ruzicka T and Jeschke MG: Hypertrophic scarring and keloids: Pathomechanisms and current and emerging treatment strategies. Mol Med. 17:113–125. 2011.PubMed/NCBI View Article : Google Scholar
4	Sidgwick GP, Iqbal SA and Bayat A: Altered expression of hyaluronan synthase and hyaluronidase mRNA may affect hyaluronic acid distribution in keloid disease compared with normal skin. Exp Dermatol. 22:377–379. 2013.PubMed/NCBI View Article : Google Scholar
5	Syed F, Ahmadi E, Iqbal SA, Singh S, McGrouther DA and Bayat A: Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: Clinical implications for lesional site-directed therapy. Br J Dermatol. 164:83–96. 2011.PubMed/NCBI View Article : Google Scholar
6	Zuccaro J, Ziolkowski N and Fish J: A systematic review of the effectiveness of laser therapy for hypertrophic burn scars. Clin Plast Surg. 44:767–779. 2017.PubMed/NCBI View Article : Google Scholar
7	Xu X, Lai L, Zhang X, Chen J, Chen J, Wang F, Zheng J and Chen M: Autologous chyle fat grafting for the treatment of hypertrophic scars and scar-related conditions. Stem Cell Res Ther. 9(64)2018.PubMed/NCBI View Article : Google Scholar
8	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004.PubMed/NCBI View Article : Google Scholar
9	Ebert MS and Sharp PA: Roles for microRNAs in conferring robustness to biological processes. Cell. 149:515–524. 2012.PubMed/NCBI View Article : Google Scholar
10	Rogers K and Chen X: Biogenesis, turnover, and mode of action of plant microRNAs. Plant Cell. 25:2383–2399. 2013.PubMed/NCBI View Article : Google Scholar
11	Hayes J, Peruzzi PP and Lawler S: MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol Med. 20:460–469. 2014.PubMed/NCBI View Article : Google Scholar
12	Wojtas B, Ferraz C, Stokowy T, Hauptmann S, Lange D, Dralle H, Musholt T, Jarzab B, Paschke R and Eszlinger M: Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas. Mol Cell Endocrinol. 388:1–9. 2014.PubMed/NCBI View Article : Google Scholar
13	Mu S, Kang B, Zeng W, Sun Y and Yang F: MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway. Mol Cell Biochem. 416:99–108. 2016.PubMed/NCBI View Article : Google Scholar
14	Hao XZ and Fan HM: Identification of miRNAs as atherosclerosis biomarkers and functional role of miR-126 in atherosclerosis progression through MAPK signalling pathway. Eur Rev Med Pharmacol Sci. 21:2725–2733. 2017.PubMed/NCBI
15	Bi S, Chai L, Yuan X, Cao C and Li S: MicroRNA-98 inhibits the cell proliferation of human hypertrophic scar fibroblasts via targeting Col1A1. Biol Res. 50(22)2017.PubMed/NCBI View Article : Google Scholar
16	Zhu HY, Li C, Bai WD, Su LL, Liu JQ, Li Y, Shi JH, Cai WX, Bai XZ, Jia YH, et al: MicroRNA-21 regulates hTERT via PTEN in hypertrophic scar fibroblasts. PLoS One. 9(e97114)2014.PubMed/NCBI View Article : Google Scholar
17	Qu F, Ye J, Pan X, Wang J, Gan S, Chu C, Chu J, Zhang X, Liu M, He H and Cui X: MicroRNA-497-5p down-regulation increases PD-L1 expression in clear cell renal cell carcinoma. J Drug Target. 27:67–74. 2019.PubMed/NCBI View Article : Google Scholar
18	Chai L, Kang XJ, Sun ZZ, Zeng MF, Yu SR, Ding Y, Liang JQ, Li TT and Zhao J: MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells. Cancer Manag Res. 10:989–1003. 2018.PubMed/NCBI View Article : Google Scholar
19	Sun Z, Li A, Yu Z, Li X, Guo X and Chen R: MicroRNA-497-5p suppresses tumor cell growth of osteosarcoma by targeting ADP ribosylation factor-like protein 2. Cancer Biother Radiopharm. 32:371–378. 2017.PubMed/NCBI View Article : Google Scholar
20	Chen Y, Kuang D, Zhao X, Chen D, Wang X, Yang Q, Wan J, Zhu Y, Wang Y, Zhang S, et al: miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma. Oncotarget. 7:58148–58161. 2016.PubMed/NCBI View Article : Google Scholar
21	Chen X, Shi C, Wang C, Liu W, Chu Y, Xiang Z, Hu K, Dong P and Han X: The role of miR-497-5p in myofibroblast differentiation of LR-MSCs and pulmonary fibrogenesis. Sci Rep. 7(40958)2017.PubMed/NCBI View Article : Google Scholar
22	Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH and ten Dijke P: Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 389:631–635. 1997.PubMed/NCBI View Article : Google Scholar
23	Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH and Wrana JL: Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell. 6:1365–1375. 2000.PubMed/NCBI View Article : Google Scholar
24	Yeung ML, Yao Y, Jia L, Chan JFW, Chan KH, Cheung KF, Chen H, Poon VKM, Tsang AKL, To KKW, et al: MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat Microbiol. 1(16004)2016.PubMed/NCBI View Article : Google Scholar
25	Liu J, Kong D, Qiu J, Xie Y, Lu Z, Zhou C, Liu X, Zhang R and Wang Y: Praziquantel ameliorates CCl₄-induced liver fibrosis in mice by inhibiting TGF-β/Smad signalling via up-regulating Smad7 in hepatic stellate cells. Br J Pharmacol. 176:4666–4680. 2019.PubMed/NCBI View Article : Google Scholar
26	Zhou R, Wang C, Wen C and Wang D: miR-21 promotes collagen production in keloid via Smad7. Burns. 43:555–561. 2017.PubMed/NCBI View Article : Google Scholar
27	Chen Z, Liu Y, Xiao M, Xiao H, Qiu W and Zhao Y: Effects of over-expressing smad7 gene on keloid fibroblasts. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 30:871–875. 2016.PubMed/NCBI View Article : Google Scholar : (In Chinese).
28	Tao J, Wang J, Li C, Wang W, Yu H, Liu J, Kong X and Chen Y: MiR-216a accelerates proliferation and fibrogenesis via targeting PTEN and SMAD7 in human cardiac fibroblasts. Cardiovasc Diagn Ther. 9:535–544. 2019.PubMed/NCBI View Article : Google Scholar
29	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
30	Lee HJ and Jang YJ: Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids. Int J Mol Sci. 19(711)2018.PubMed/NCBI View Article : Google Scholar
31	Aberdam D, Candi E, Knight RK and Melino G: miRNAs, ‘sternness’ and skin. Trends Biochem Sci. 33:583–591. 2008.PubMed/NCBI View Article : Google Scholar
32	Botchkareva NV: MicroRNA/mRNA regulatory networks in the control of skin development and regeneration. Cell Cycle. 11:468–474. 2012.PubMed/NCBI View Article : Google Scholar
33	Chen L and Li J, Li Q, Yan H, Zhou B, Gao Y and Li J: Non-coding RNAs: The new insight on hypertrophic scar. J Cell Biochem. 118:1965–1968. 2017.PubMed/NCBI View Article : Google Scholar
34	Tsai CH and Ogawa R: Keloid research: Current status and future directions. Scars Burn Heal. 5(2059513119868659)2019.PubMed/NCBI View Article : Google Scholar
35	Zhang Q, Guo B, Hui Q, Chang P and Tao K: miR-137 inhibits proliferation and metastasis of hypertrophic scar fibroblasts via targeting pleiotrophin. Cell Physiol Biochem. 49:985–995. 2018.PubMed/NCBI View Article : Google Scholar
36	Wu X, Li J, Yang X, Bai X, Shi J, Gao J, Li Y, Han S, Zhang Y, Han F, et al: miR-155 inhibits the formation of hypertrophic scar fibroblasts by targeting HIF-1α via PI3K/AKT pathway. J Mol Histol. 49:377–387. 2018.PubMed/NCBI View Article : Google Scholar
37	Zhou X, Xie Y, Xiao H, Deng X, Wang Y, Jiang L, Liu C and Zhou R: MicroRNA-519d inhibits proliferation and induces apoptosis of human hypertrophic scar fibroblasts through targeting Sirtuin 7. Biomed Pharmacother. 100:184–190. 2018.PubMed/NCBI View Article : Google Scholar
38	Wang X, Zhang Y, Jiang BH, Zhang Q, Zhou RP, Zhang L and Wang C: Study on the role of Hsa-miR-31-5p in hypertrophic scar formation and the mechanism. Exp Cell Res. 361:201–209. 2017.PubMed/NCBI View Article : Google Scholar
39	Zunwen L, Shizhen Z, Dewu L, Yungui M and Pu N: Effect of tetrandrine on the TGF-β-induced smad signal transduction pathway in human hypertrophic scar fibroblasts in vitro. Burns. 38:404–413. 2012.PubMed/NCBI View Article : Google Scholar
40	Liu B, Li J and Cairns MJ: Identifying miRNAs, targets and functions. Brief Bioinform. 15:1–19. 2014.PubMed/NCBI View Article : Google Scholar
41	Lu TX and Rothenberg ME: MicroRNA. J Allergy Clin Immunol. 141:1202–1207. 2018.PubMed/NCBI View Article : Google Scholar